145 related articles for article (PubMed ID: 15756433)
1. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients.
Hasegawa S; Seike K; Koda K; Takiguchi N; Oda K; Hasegawa R; Miyazaki M
Oncol Rep; 2005 Apr; 13(4):621-6. PubMed ID: 15756433
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer.
Yamaue H; Tanimura H; Kono N; Aoki Y; Tabuse K; Uchiyama K; Takifuji K; Iwahashi M; Tani M
Anticancer Res; 2003; 23(3B):2559-64. PubMed ID: 12894541
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Takahashi K; Saito T
Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
[TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
Ikeguchi M; Makino M; Kaibara N
Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
[TBL] [Abstract][Full Text] [Related]
13. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidine nucleoside phosphorylase and dihydropyrimidine dihydrogenase activities as predictive factors for the efficacy of doxifluridine together with mitomycin C as adjuvant chemotherapy in primary colorectal cancer.
Nishioka M; Miyamoto H; Kurita N; Higashijima J; Yoshikawa K; Miyatani T; Shimada M
Hepatogastroenterology; 2007 Jun; 54(76):1089-93. PubMed ID: 17629045
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.
Tominaga T; Toi M; Ohashi Y; Abe O;
Clin Breast Cancer; 2002 Apr; 3(1):55-64. PubMed ID: 12020396
[TBL] [Abstract][Full Text] [Related]
16. Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.
Mimori K; Ueo H; Kuroki T; Shiraishi T; Creer S; Taylor S; Ishii H; Mori M
Oncol Rep; 2004 Jul; 12(1):19-23. PubMed ID: 15201953
[TBL] [Abstract][Full Text] [Related]
17. [Thymidine phosphorylase expressed in monocyte-macrophages enhanced anticancer effect of 5'-deoxy-5-fluorouridine on colorectal carcinoma cells].
Zhang JM; Liu MJ; Mizoi T; Shiiba K; Sasak I; Matsuno S
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):718-24. PubMed ID: 15200906
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced anticancer effects of 5'-DFUR on colorectal cancer cell lines SW480 and LOVO by transfection with thymidine phosphorylase cDNA].
Liu J; Zhang JM; Gao Q; Wang QW; Ye DJ; Liu Y
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):636-40. PubMed ID: 24256592
[TBL] [Abstract][Full Text] [Related]
20. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]